FDA-Inspected Site

Respa Pharmaceuticals Inc.

4 FDA inspections are on record for Respa Pharmaceuticals Inc. in Addison, United States.

483· Form 483 issued

Addison, United States · Last updated July 11, 2026

Overview

  • 4 FDA inspections are on record.
  • 2 inspections produced a Form 483.
  • The most recent recorded inspection date is 2012-10-04.

At a glance

Inspections

4

Form 483s

2

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
4 Oct 2012Not recorded483View 483 →
4 Aug 2011Not recorded483View 483 →
29 Sep 2006Not recordedClean
13 Sep 2005Not recordedClean

Observations on record

Form 483 observations cited at this site, most recent first.

4 Oct 2012
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Debra I Love

4 Oct 2012
21 CFR 211.198(a)

Complaint Handling Procedure

Cited by Debra I Love

4 Oct 2012
FDCA 501(a)

Drug Field Exam

Cited by Debra I Love

4 Aug 2011
21 CFR 211.22(a)

Authority lacking to review records, investigate errors

Cited by Debra I Love, Denarvis C Mendenhall

4 Aug 2011
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Debra I Love, Denarvis C Mendenhall

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.22(d)Cited across public-safe Form 483 observations2x
21 CFR 211.142(a)Cited across public-safe Form 483 observations1x
21 CFR 211.150Cited across public-safe Form 483 observations1x
21 CFR 211.198(a)Cited across public-safe Form 483 observations1x
21 CFR 211.22(a)Cited across public-safe Form 483 observations1x
21 CFR 211.25(a)Cited across public-safe Form 483 observations1x
FDCA 501(a)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Respa Pharmaceuticals Inc.'s 2 Form 483s

Verbatim observations and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat